Culture

Response to infection therapy better understood thanks to a new technique

Infectious diseases are caused by pathogenic viruses, bacteria, fungi or parasites. The treatment of bacterial and fungal infections relies particularly on antimicrobial drugs, while the focus in treating viral infections is the alleviation of symptoms.

Initial therapy for infection is often empiric and guided by clinical presentation. Its efficacy on the pathogen is, however, only seldom understood at therapy initiation. Although methods for assessing treatment responses exist, the effectiveness is mainly determined through monitoring symptoms and signs of infections.

Advances in sequencing technology have made characterization of genomes and gene expression products increasingly practical. The technology has also made it possible to identify microbiota components up to species- and gene-level. Nevertheless, microbiota sequencing is only occasionally employed in infection treatment.

Now, researchers at the University of Helsinki have, together with their collaborators at the Helsinki University Hospital, developed a new sequencing-based approach for pathogen discovery from challenging samples. The approach and preliminary results on its usage in burn wound infection clearance assessment have been published in the Clinical Microbiology and Infection journal.

"The approach enables to capture the real-time functional activities of even minuscule amounts of microbes. It can be used to reliably investigate the activity of microbial drug resistance mechanisms and other microbial mechanisms relevant to infection or its treatment. This helps to understand whether causative microbes are alive or dying and what they do," says bioinformatician Matti Kankainen, PhD, from the University of Helsinki.

Technique sheds light on pathogen activities

The underlying principle of the technique is as follows: a clinical sample is taken from the patient and its RNA, the underlying foundation of biological processes, is extracted. Next, the microbial RNA is enriched to magnify pathogen information. The RNA is sequenced and the extensive amounts of data gained are analysed by novel algorithms.

To understand the value of the approach in clinical practice, the researchers applied their solution to a complicated wound infection case. The study subject was a wound infection patient that had been treated with several antibiotic therapies for almost one hundred days unsuccessfully. In spite of the therapies, the infection recurred. Briefly following the start of the fourth antibiotic regimen, the researchers collected samples from the infection site. The samples were analysed using their approach as well as with the help of the more common 16S DNA-gene profiling. Corresponding samples were collected also from a control subject.

The fourth antibiotic regimen proved to be effective and alleviated symptoms. The results gained using the new approach agreed the clinical presentation and confirmed the elimination of the pathogen. Furthermore, they demonstrated the recovery of the normal microbiota. A similar microbiota change was not seen in the 16S profiling. Instead, candidate pathogens of the infection were identified, due to the slow breakdown of DNA.

Metatranscriptomics may be the answer to diagnosing infectious diseases

The used approach is known as metatranscriptomics. It allows the comprehensive determination of microbial gene activity. Its use has become increasingly prevalent, but problems related to handling and analysis of challenging host-microbe samples have prevented the more widespread clinical use of metatranscriptomics.

"Our findings demonstrate that our solution suits also to challenging samples that contain minuscule amounts of microbes. On top of pathogen identification, it can be used to characterise host-microbe interaction. It may thereby shed light into yet-unidentified disease mechanisms. We will develop the technique further as a part of infection studies ongoing at our laboratory. Further work will also focus on understanding its application spectrum," says Esko Kankuri, docent in pharmacology at the University of Helsinki.

Postdoctoral Researcher Teija Ojala from the University of Helsinki developed the new approach. Next, Ojala will utilise the technique to advance our understanding on COVID-19 coronavirus disease.

Credit: 
University of Helsinki

Machine-learning models of matter beyond interatomic potentials

image: Electronic densities of states (DOS) at various stages of the compression run

Image: 
@Michele Ceriotti

Combining electronic structure calculations and machine learning (ML) techniques has become a common approach in the atomistic modelling of matter. Using the two techniques together has allowed researchers, for instance, to create models that use atomic coordinates as the only inputs to inexpensively predict any property that can be computed by the first-principles calculations that had been used to train them.

While the earliest and by now most advanced efforts have focused on using predictions of total energies and atomic forces to construct interatomic potentials, more recent efforts have targeted additional properties of crystals and molecules such as ionization energies, NMR chemical shieldings, dielectric response properties and charge density. In the paper "Learning the electronic density of states in condensed matter," Ceriotti and colleagues focus on the electronic density of states (DOS), another quantity that underlies many useful materials properties, some of which can be observed experimentally.

The DOS is essentially the number of different states that electrons can occupy at a particular energy level and can be used, for instance, to calculate the electronic contribution to heat capacity in metals and the density of free charge carriers in semiconductors. It is an indirect proxy for properties such as the energy band gap, the band energy and the optical absorption spectrum.

"Predicting the DOS is an interesting exercise in itself because it is essentially the simplest possible description of the electronic structure beyond the ground state picture," Ceriotti said. "It's also useful because there are many properties that you can compute starting from the DOS, making it a great example of how the next generation of ML models can be used in a similar way as electronic structure calculations, using them in an indirect way to compute intermediate quantities that can then be easily processed to evaluate properties that are harder to learn directly."

In developing the model, the group looked to assure transferability across different phases as well as scalability to large system sizes. Their ultimate approach, which looks at how different atomic configurations affect the distribution of energy levels, meets these goals--it was able to learn and predict DFT-computed DOS for a diverse data set of silicon structures, covering a broad range of thermodynamic conditions and different phases. It also scales linearly, rather than with the cube of the number of atoms as with electronic structure calculations, making it applicable to large structures. Finally, the model allowed for an analysis of the local DOS, giving researchers the chance to examine the interplay between structural motifs and electronic structure.

The combination of transferability, and scalability of predictions to large system sizes, make the model applicable to address long-standing open questions in materials science. The new framework has already been used to elucidate the electronic properties of a 100'000-atoms simulation of amorphous silicon, undergoing a series of phase transitions when compressed to 20 Gpa, in a paper published in Nature today in collaboration with a team comprising researchers from Oxford, Cambridge, the US Naval Research Laboratory and Ohio University. The predicted DOS is also used to explain how the pressure-induced structural transformations couple to the electronic structure of the material.

Combining the new model with one of the well-established potential energy models also makes it possible to compute the electronic contributions to macroscopic properties such as the heat capacity of metals and to perform simulations that take into account finite-electronic-temperature effects - as demonstrated in another soon-to-be published article discussing the high-temperature properties of nickel. Indeed, the new model is a critical step towards MARVEL's goal of developing integrated machine learning models that augment - and perhaps eventually replace - costly electronic structure calculations.

"There are other properties aside from the electron density of states, such as optical excitations, and NMR response, which we have been able to accurately predict with machine learning." Ceriotti said. "If we can use them all in combination with cheap and accurate interatomic potentials it will allow us to describe all of the properties of materials with the same accuracy achieved with electronic structure calculation, but at a tiny fraction of the cost."

Credit: 
National Centre of Competence in Research (NCCR) MARVEL

When galaxies collide: Hubble showcases six beautiful galaxy mergers

image: To celebrate a new year, the NASA/ESA Space Telescope has published a montage of six beautiful galaxy mergers. Each of these merging systems was studied as part of the recent HiPEEC survey to investigate the rate of new star formation within such systems. These interactions are a key aspect of galaxy evolution and are among the most spectacular events in the lifetime of a galaxy.

Image: 
ESA/Hubble, NASA, the Hubble Heritage Team (STScI/AURA)-ESA/Hubble Collaboration and A. Evans (University of Virginia, Charlottesville/NRAO/Stony Brook University), A. Adamo et al.

It is during rare merging events that galaxies undergo dramatic changes in their appearance and in their stellar content. These systems are excellent laboratories to trace the formation of star clusters under extreme physical conditions.

The Milky Way typically forms star clusters with masses that are 10 thousand times the mass of our Sun. This doesn't compare to the masses of the star clusters forming in colliding galaxies, which can reach millions of times the mass of our Sun.

These dense stellar systems are also very luminous. Even after the collision, when the resulting galactic system begins to fade into a more quiescent phase, these very massive star clusters will shine throughout their host galaxy, as long-lasting witnesses of past merging events.

By studying the six galaxy mergers shown here, the Hubble imaging Probe of Extreme Environments and Clusters (HiPEEC) survey has investigated how star clusters are affected during collisions by the rapid changes that drastically increase the rate at which new stars are formed in these galaxies. Hubble's capabilities have made it possible to resolve large star-forming "knots" into numerous compact young star clusters. Hubble's ultraviolet and near-infrared observations of these systems have been used to derive star cluster ages, masses, and extinctions and to analyse the star formation rate within these six merging galaxies. The HiPEEC study reveals that the star cluster populations undergo large and rapid variations in their properties, with the most massive clusters formed towards the end of the merger phase.

Credit: 
ESA/Hubble Information Centre

When Uber and Lyft enter cities, vehicle ownership increases

image: This graphical abstract depicts findings for what happens when Uber and Lyft enter U.S. cities.

Image: 
Jeremy Michalek

When ridesourcing companies Uber and Lyft show up in urban areas, vehicle registrations per capita increase by 0.7% on average, increasing even more in car-dependent cities. Researchers reporting in the journal iScience on January 6 made this discovery by analyzing data from major US cities between 2011 to 2017, comparing trends in cities where Uber and Lyft entered with those where they didn't. They also found that Uber and Lyft displace transit more in cities with higher income and fewer children.

"I would have expected people to own fewer vehicles once they gain access to this alternative transportation mode," says Jeremy Michalek, a professor of engineering and public policy at Carnegie Mellon University and co-author on the study. "But that's not what we see in the data. One possible explanation could be that there's an effect on the other side, where somebody who was on the verge of being able to afford a vehicle now has an incentive to buy one and earn some money with it. So vehicle adoption by Uber and Lyft drivers may outweigh the effect of riders getting rid of their personal vehicles."

The researchers also investigated the impact of ridesourcing services on transit use. While there wasn't a significant effect on average, they did find that cities with higher income and fewer children see a bigger reduction in transit use.

"What this suggests to me is that in a city where people have disposable income and fewer children, they don't mind paying more for a more convenient mode of transportation, and they don't have to worry about logistics like bringing a car seat," says Michalek.

While the researchers were able to identify trends across cities in their data analysis, they are also interested in investigating how these trends stack up in specific cities. Additionally, their analysis only accounts for pre-pandemic patterns that have certainly changed because of COVID-19.

"Of course, the pandemic has caused enormous changes in ridesourcing, public transit, and transportation trends in general. With many employees working from home, and many others opting to use personal vehicles for travel, ridesourcing services have seen a drop in riders," says Michalek. "The question is, once the pandemic is behind us, do we return to the kinds of travel patterns and choices we saw before the pandemic, or are there systemic changes that won't go back to normal because people have permanently changed their behavior? We won't know for sure until it happens."

Credit: 
Cell Press

DNA-editing method shows promise to treat mouse model of progeria

image: Progeria is caused by a mutation in the nuclear lamin A gene in which one DNA base C is changed to a T. Researchers used the base editing method, which substitutes a single DNA letter for another without damaging the DNA, to reverse that change.

Image: 
Ernesto del Aguila III, NHGRI

Researchers have successfully used a DNA-editing technique to extend the lifespan of mice with the genetic variation associated with progeria, a rare genetic disease that causes extreme premature aging in children and can significantly shorten their life expectancy. The study was published in the journal Nature, and was a collaboration between the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health; Broad Institute of Harvard and MIT, Boston; and the Vanderbilt University Medical Center, Nashville, Tennessee.?

DNA is made up of four chemical bases -- A, C, G and T. Progeria, which is also known as Hutchinson-Gilford progeria syndrome, is caused by a mutation in the nuclear lamin A?(LMNA) gene in which one DNA base C is changed to a T. This change increases the production of the toxic protein progerin, which causes the rapid aging process.

Approximately 1 in 4 million children are diagnosed with progeria within the first two years of birth, and virtually all of these children develop health issues in childhood and adolescence that are normally associated with old age, including cardiovascular disease (heart attacks and strokes), hair loss, skeletal problems, subcutaneous fat loss and hardened skin.

For this study, researchers used a breakthrough DNA-editing technique called base editing, which substitutes a single DNA letter for another without damaging the DNA, to study how changing this mutation might affect progeria-like symptoms in mice.

"The toll of this devastating illness on affected children and their families cannot be overstated," said Francis S. Collins, M.D., Ph.D., a senior investigator in NHGRI's Medical Genomics and Metabolic Genetics Branch, NIH director and a corresponding author on the paper. "The fact that a single specific mutation causes the disease in nearly all affected children made us realize that we might have tools to fix the root cause. These tools could only be developed thanks to long-term investments in basic genomics research."

The study follows another recent milestone for progeria research, as the U.S. Food and Drug Administration approved the first treatment for progeria in November 2020, a drug called lonafarnib. The drug therapy provides some life extension, but it is not a cure. The DNA-editing method may provide an additional and even more dramatic treatment option in the future.

David Liu, Ph.D., and his lab at the Broad Institute developed the base-editing method in 2016, funded in part by NHGRI.

"CRISPR editing, while revolutionary, cannot yet make precise DNA changes in many kinds of cells," said Dr. Liu, a senior author on the paper. "The base-editing technique we've developed is like a find-and-replace function in a word processor. It is extremely efficient in converting one base pair to another, which we believed would be powerful in treating a disease like progeria."

To test the effectiveness of their base-editing method, the team initially collaborated with the Progeria Research Foundation to obtain connective tissue cells from progeria patients. The team used the base editor on the?LMNA?gene within the patients' cells in a laboratory setting. The treatment fixed the mutation in 90% of the cells.

"The Progeria Research Foundation was thrilled to collaborate on this seminal study with Dr. Collins's group at the NIH and Dr. Liu's group at Broad Institute," said Leslie Gordon, M.D., Ph.D., a co-author and medical director of The Progeria Research Foundation, which partially funded the study. "These study results present an exciting new pathway for investigation into new treatments and the cure for children with progeria."

Following this success, the researchers tested the gene-editing technique by delivering a single intravenous injection of the DNA-editing mix into nearly a dozen mice with the progeria-causing mutation soon after birth. The gene editor successfully restored the normal DNA sequence of the?LMNA?gene in a significant percentage of cells in various organs, including the heart and aorta.

Many of the mice cell types still maintained the corrected DNA sequence six months after the treatment. In the aorta, the results were even better than expected, as the edited cells seemed to have replaced those that carried the progeria mutation and dropped out from early deterioration. Most dramatically, the treated mice's lifespan increased from seven months to almost 1.5 years. The average normal lifespan of the mice used in the study is two years.

"As a physician-scientist, it's incredibly exciting to think that an idea you've been working on in the laboratory might actually have therapeutic benefit," said Jonathan D. Brown, M.D., assistant professor of medicine in the Division of Cardiovascular Medicine at Vanderbilt University Medical Center. "Ultimately our goal will be to try to develop this for humans, but there are additional key questions that we need to first address in these model systems."

Credit: 
NIH/National Human Genome Research Institute

Designer protein patches boost cell signaling

image: Illustration of a designed protein array on a cell surface. This new class of protein material interacts with living cells without being absorbed by them and can influence cell signaling. It does this by binding and sequestering cell surface receptors.

Image: 
Ian Haydon, UW Medicine Institute for Protein Design

A new class of protein material that interacts with living cells without being absorbed by them can influence cell signaling, a new study shows. The material does this by binding and sequestering cell surface receptors.

The discovery could have far-reaching implications for stem cell research and enable the development of new materials designed to modulate the behavior of living systems.

The research, reported in the January 6 edition of Nature, was led by the Baker lab at the University of Washington School of Medicine and the Derivery lab at the Medical Research Council Laboratory of Molecular Biology in Cambridge, U.K. Their paper is titled, Design of Biologically Active Binary Protein 2D Materials.

Cells interact with their environment via receptors at their surface. These receptors can bind to hormones, neurotransmitters, drugs, and toxins. When such molecules bind to a receptor, this triggers a response inside the cell, a process known as signaling.

But for the cell, it is important that this response be transient, to still be responsive to the signal later on. To achieve this, cells will commonly terminate signaling by absorbing both an activated receptor and the molecule that stimulated it, thereby targeting both for destruction inside the cell.

"This tendency of cells to internalize receptors likely lowers the efficiency of immunotherapies," said Emmanuel Derivery, assistant professor at the MRC Laboratory of Molecular Biology. "Indeed, when antibody drugs bind their target receptors and then become internalized and degraded, more antibody must always be injected."

To create a way around this, Baker lab postdoctoral scholar Ariel Ben-Sasson designed new proteins that assemble into large, flat patches. This molecular scaffolding was then further engineered to contain signaling molecules.

Graduate student Joseph Watson of the Derivery lab showed that such protein materials could latch onto cells, activate surface receptors, and resist being absorbed by the cell for hours or even days.

"This work paves the way towards a synthetic cell biology, where a new generation of multi-protein materials can be designed to control the complex behavior of cells," said David Baker, professor of biochemistry at the UW School of Medicine and director of the UW Medicine Institute for Protein Design.

By swapping out which cell surface receptors were targeted by the patch, the researchers showed that different cell types could be activated.

"We now have a tool that can interact with any type of cells in a very specific way," said Ben-Sasson. "This is what is exciting about protein engineering: it opens fields that people may not expect."

According to co-author Hannele Ruohola-Baker, professor of biochemistry at the UW School of Medicine and associate director of the UW Medicine Institute for Stem Cell and Regenerative Medicine, versions of these new materials could eventually help physicians alleviate the dangers of sepsis by controlling the inflammatory response to infection.

They might even enable entirely new ways to treat COVID-19, heart disease, and diabetes, and perhaps mitigate the downstream effects of strokes, including Alzheimer's disease.

"This breakthrough helps pave the way for the use of synthetic cell biology in regenerative medicine," said Ruohola-Baker.

Credit: 
University of Washington School of Medicine/UW Medicine

Will global warming bring a change in the winds? Dust from the deep sea provides a clue

image: Image of a dust plume leaving China and crossing the Korean Peninsula and Japan. Researchers studied the dust deposited in ancient ocean sediments in order to understand how wind patterns in this area have shifted in the past. Their findings provide a better understanding of how the winds may change in the future.

Image: 
SeaWiFS Project, NASA/Goddard Space Flight Center, and ORBIMAGE

The westerlies--or westerly winds--play an important role in weather and climate both locally and on a global scale, by influencing precipitation patterns, impacting ocean circulation and steering tropical cyclones. So, finding a way to assess how they will change as the climate warms is crucial.

Typically, the westerlies blow from west to east across the planet's middle latitudes. But scientists have noticed that over the last several decades, these winds are changing, migrating poleward. Research suggests this is because of climate change. But, scientists have been debating whether the poleward movement of the westerlies will continue as temperatures and atmospheric carbon dioxide (CO2) increase further under future warming scenarios. It's been difficult to resolve this scientific question because our knowledge of the westerlies in past warm climates has until now been limited.

In a paper published January 6 in Nature, climate researchers from Columbia University's Lamont-Doherty Earth Observatory describe a new method of tracking the ancient history of the westerly winds--a proxy for what we may experience in a future warming world. The lead author, Lamont graduate student Jordan Abell and his advisor, Gisela Winckler, developed a way to apply paleoclimatology--the study of past climate--to the question of the behavior of the westerly winds, and found evidence suggesting that atmospheric circulation patterns will change with climate warming.

The finding represents a breakthrough in our understanding of how the winds changed in the past, and how they may continue to change in the future.

By using dust in ancient, deep sea sediments as an indirect tracer of wind, the researchers were able to reconstruct wind patterns that occurred three to five million years ago. Knowing that winds--in this case the westerlies--transport dust from desert regions to faraway locations, the authors examined cores from the North Pacific Ocean. This area is downwind from Eastern Asia, one of the largest dust sources today and a known dust-generating region for the past several million years. By measuring the dust in cores from two different sites thousands of kilometers apart, the researchers were able to map changes in dust, and in turn the westerly winds.

"We could immediately see the patterns. The data are so clear. Our work is consistent with modern observations, and suggests that wind patterns will change with climate warming," said Abell.

They found that during the warm parts of the Pliocene (a period three to five million years ago, when the Earth was about two to four degrees Celsius warmer than today but had approximately the same concentration of CO2 in the air as we do now), the westerlies, globally, were located closer towards the poles than during the colder intervals afterwards.

"By using the Pliocene as an analogue for modern global warming, it seems likely that the movement of the westerlies towards the poles observed in the modern era will continue with further human-induced warming," explained Winckler.

The movement of these winds have huge implications for storm systems and precipitation patterns. And while this research does not indicate exactly where it will rain more or less, it confirms that the wind and precipitation patterns will change with climate warming.

"In the Earth history record, tracking down movements of wind and how they've changed, that's been elusive because we didn't have a tracer for it," said Winckler. "Now we do."

Credit: 
Columbia Climate School

COVID-19 maps, public knowledge, risk perceptions and behavioral intentions

What The Study Did: The findings of this survey study suggest that simply providing maps with COVID-19 case information wasn't necessarily associated with improved public knowledge, risk perception or reported intent to adhere to health guidelines.

Authors: Angela Fagerlin, Ph.D., of the University of Utah in Salt Lake City, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2020.33538)

Editor's Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Credit: 
JAMA Network

Mental health of UK women, ethnic minorities especially affected during pandemic

image: Average GHQ-12 in 2017-2019 and April 2020 among BAME and White British individuals by gender.

Image: 
Proto E, Quintana-Domeque C (2021) PLOS ONE

In the UK, men from ethnic minorities and women may have experienced worse mental health declines than White British men, according to a study published January 6, 2021 in the open access journal PLOS ONE by Eugenio Proto and Climent Quintana-Domeque of institutions including the University of Glasgow and the University of Exeter, UK.

The COVID-19 pandemic, and the measures enacted to restrict the spread of the virus, have had a major impact on the lives of citizens globally. The authors of the present study examined changes in mental health associated with the pandemic across ethnic groups in the UK.

The researchers used data from the UK Household Longitudinal Study, comparing responses from participants between 2017 and 2019 (i.e.: prior to the pandemic) to responses from the same participants in April 2020 (i.e.: during the pandemic, when severe "lockdown" restrictions were in place in the UK). A total of 14,523 individuals provided responses both before and during the pandemic; 91.5 percent defined their ethnicity as White British and the remaining 8.5 percent as another ethnicity (Black, Asian, and minority ethnic, or BAME). Participants were asked to self-report their health, including their mental wellbeing. These responses were used to measure levels of mental distress, on a scale from 0 to 36.

The authors found that the average mental distress for individuals had increased from 11.28 [95% CI: 11.17, 11.40] in 2017-2019 to 12.51 [95% CI: 12.38, 12.63] in April 2020, a 0.21 standard deviation increase [95% CI: 0.19, 0.23]. Women experienced a greater average increase in mental distress than men, and BAME men also experienced a greater average increase than White British men. While White British men saw an average increase in mental distress of 0.6 units on this scale, White British women experienced an average increase of 1.6 units. BAME men experienced an average increase of 1.5 units, and BAME women of 1.7 units.

While the study conclusions may be limited by the sample size of BAME individuals (only 1,066 of the participants defined themselves as BAME), and by mental distress being measured relatively early on in the pandemic, the research suggests that the pandemic may have particularly affected the mental wellbeing of women and BAME individuals. The authors state that their preliminary findings appear to indicate "the impact of the lockdown and social distancing requirements on mental health being worse among minority ethnic groups."

The authors add: "Women and Black, Asian, and minority ethnic men experienced a higher average increase in mental distress than White British men from 2017-2019 to April 2020."

Credit: 
PLOS

Scientists create ON-OFF switches to control CAR T cell activity

CAR T cells are a breakthrough class of effective but often toxic cancer therapies

To prevent overactivation, switchable CAR T cells were engineered that can be turned on and off with an approved, widely used cancer drug

BOSTON - Scientists at Dana-Farber Cancer Institute and Mass General Cancer Center have created molecular ON-OFF switches to regulate the activity of CAR T cells, a potent form of cell-based immunotherapy that has had dramatic success in treating some advanced cancers, but which pose a significant risk of toxic side effects.

CAR T cells are immune cells genetically modified to recognize and attack tumors cells. Once given, these "living drugs" proliferate and kill tumor cells over weeks to months, in some cases causing life-threatening inflammatory reactions that are difficult to control. In this way, CAR T cells are unlike more established forms of cancer therapy - chemotherapy or radiotherapy for instance - whose dose can be precisely tuned up or down over time.

The scientists reported in Science Translational Medicine the development of switchable CAR T cells that can be turned on or off by giving a commonly used cancer drug, lenalidomide. In the laboratory, the researchers designed OFF-switch CAR T cells that could be quickly, reversibly turned off by administering the drug, after which the CAR T cells recovered their anti-tumor activity. Separately, the researchers also reported ON-switch CAR T cells that only killed tumor cells during lenalidomide treatment.

In the future, switchable cell therapies might allow patients with their physicians to take a pill - or not - to tune the amount of CAR T cell activity from day to day, hopefully reducing toxic side effects.

"From the start, our goal was to build cancer therapies that are less hard on people. Having built these switches using human genetic sequences and an FDA-approved drug, we are excited for the potential to translate this research to clinical use," said Max Jan, MD, PhD, first author of the report. He is affiliated with the laboratories of Benjamin Ebert, MD, PhD, and Marcela Maus, MD, PhD, the report's senior authors. Other authors include researchers from the Broad Institute of MIT and Harvard, and Harvard Medical School.

CAR T cells are created by harvesting immune T cells from the patient and reprogramming them in the laboratory to produce a finely-tuned receptor molecule, termed a CAR (for chimeric antigen receptor), that recognizes a distinctive protein on the surface of the patient's cancer cells. The CAR T cells, after being engineered in the lab and returned to the patient, circulate through the body and home in on the cancer cells by binding to the distinctive surface protein they have been engineered to recognize. This binding event stimulates an immune attack, destruction of the cancer cells, and proliferation of the CAR T cells.

A drawback, however, is that uncontrolled proliferation of the CAR T cells sometimes triggers cytokine release syndrome (CRS), the release of inflammation-causing signals throughout the body that can cause toxicities ranging from mild fever to life-threatening organ failure. Current management of these toxic reactions relies on intensive care unit support and drugs including immunosuppressive corticosteroids, while many researchers are trying to develop methods of controlling the activity of CAR T cells in order to prevent these toxic side effects.

"CAR T cells can be fantastically effective therapies, but they can also have serious toxicities and can cause significant morbidity and mortality," said Ebert who is Chair of Medical Oncology at Dana-Farber. "They are currently difficult to control once administered to the patient."

CAR T cell therapy has had most success in blood cancers. Three CAR T agents have been approved: Kymriah for children and young adults with B-cell precursor acute lymphoblastic leukemia (ALL), both Kymriah and Yescarta for treatment of adults with diffuse large B-cell lymphoma and Tecartus for adults with mantle cell lymphoma. Scientists are investigating an array of different approaches with the aim of extending the reach of CAR T therapies to other blood cancers and to solid tumors, if a number of hurdles can be overcome, including the problem of treatment toxicity.

To create the ON and OFF switch systems for CAR T cells, the scientists used a relatively new technique known as targeted protein degradation. It exploits a mechanism that cells use to dispose of unwanted or abnormal proteins; the proteins are marked for destruction by a structure within cells that acts like a garbage disposal. A small number of drugs, including lenalidomide, act by targeting specific proteins for degradation using this pathway.

The researchers used this technique to engineer small protein tags that are sent to the cellular garbage disposal by lenalidomide. When this degradation tag was affixed to the CAR, it allowed the tagged CAR to be degraded during drug treatment, thereby stopping T cells from recognizing cancer cells. Because CAR proteins are continually manufactured by these engineered T cells, after drug treatment new CAR proteins accumulate and restore the cell's anti-tumor function. The researchers propose that the switch system might in the future allow patients to have their CAR T cell treatment temporarily paused to prevent short-term toxicity and still have long-term therapeutic effects against their cancer.

The scientists also built an ON-switch CAR by further engineering the proteins that physically interact with lenalidomide. This system has the potential to be especially safe, because the T cells only recognize and attack tumor cells during drug treatment. If used to treat cancers such as multiple myeloma that are sensitive to lenalidomide, ON-switch CAR T cells could allow for a coordinated attack by the immune cells and the drug that controls them.

"The long-term goal is to have multiple different drugs that control different on and off switches" so that scientists can develop "ever-more complex cellular therapies," explained Ebert.

Credit: 
Dana-Farber Cancer Institute

New evidence: Effects of Huntington's disease mutation may begin in childhood

image: Theories of the etiology of Huntington's disease.

Image: 
Journal of Huntington's Disease.

Amsterdam, NL, January 6, 2021 - There is growing evidence to support the hypothesis that there is a neurodevelopmental component to the late-onset neurodegeneration occurring in the brain of huntingtin gene (HTT gene) mutation carriers, and that this increased susceptibility to brain cell death begins during childhood. Experts discuss the evidence that the HTT gene mutation affects brain and body growth based on a unique study of children at risk for HD, the Kids-HD study, in a review paper and accompanying research article published in the Journal of Huntington's Disease.

The classic concept is that Huntington's disease is caused by toxic mutant huntingtin (mHTT) acting over time on mature brain cells. However, there is growing evidence for an alternative theory in which mHTT has an effect on brain development and that this altered development plays a vital role in the later degenerative process. This theory is based on the notion that wild-type huntingtin (HTT) function plays a role in normal brain development.

"Although the gene was discovered in 1993, we still don't have a good understanding of what causes HD - how does the mutant gene cause brain cells to become 'sick' then die?" noted lead investigator Peg C. Nopoulos, MD, Department of Psychiatry, Department of Pediatrics, and Department of Neurology, University of Iowa Carver College of Medicine, Iowa City, IA, USA. "The neurodevelopmental hypothesis is a relatively new way of thinking about the disease and can help focus research efforts in a new direction. This review and the accompanying study are important in reshaping our ideas about how we view the nature and timing of preventive treatment for HD and the factors that contribute to disease."

The neurodevelopmental hypothesis of HD posits that the disease-causing gene mutation affects development of a specific region or specific brain circuit. These cells are abnormal in their growth; however, they are compensated for early in life. Therefore, despite abnormal development, there are no overt symptoms. The abnormally developed cells remain in a "mutant steady state." These cells are then vulnerable to dysfunction and degeneration later in life when they are subjected to stresses and strains, either normal (programmed synaptic elimination during puberty or through the aging process) or pathological (toxic effects of mHTT). In the end, the disease pathology results in neural degeneration with its accompanying cognitive and motor deficits.

The two papers focus on the most recent findings from Kids-HD, a unique brain imaging study of children aged six to 18 years old at risk for HD because they have a parent or grandparent with HD. The review discusses the effects of mHTT on brain development and the study evaluates the effect of mHTT on body development.

According to the authors, there is evidence in children as young as 6 who carry a mutation in the HTT gene, that production of mHTT alters the growth and development of the striatum and related circuitry. The gene contains a sequence of three DNA bases - cytosine-adenine-guanine (CAG) - repeated multiple times. The developmental changes appear to be influenced by the CAG repeat length and occur well before onset of symptoms of the disease. Deficits may then be compensated for by increased activity in other brain circuits, particularly those involving the cerebellum, and are manifest only when compensatory systems are no longer working.

The body development analysis used data from the 186 children in the Kids-HD study. Investigators applied simple measures of growth - height, weight, and the combined BMI measure - to compare changes in two groups - those who carried the CAG repeat expansion mutation in the HTT gene and those who did not.

Around puberty the study began to show an altered trajectory of growth in HTT gene mutation carriers. The pace at which their BMI increased slowed over time so that at by about 17 years old, that group had substantially lower BMI than the group without the gene mutation. Boys with the gene mutation tended to be taller than the control group, but with lower weight; girls with the gene mutation tended to be around the same height, but lower in weight.

Importantly, although the gene mutation carriers were roughly 30 years from the expected time of onset of the disease, the mutant HTT gene had already affected their growth and development. This work is important because it suggests that the mutation is altering the body even before the onset of neurological disease in midlife.

Gene therapy trials are currently underway to evaluate the effectiveness of drugs to slow disease progression in affected individuals, and future trials will ultimately aim to prevent disease onset by delivery of gene therapy to gene mutation carriers - those with mHTT, but no symptoms.

"Gene therapy trials are finally here. However, interfering with a gene responsible for brain development early in life must be done with an abundance of caution," commented Dr. Nopoulos. "Understanding how mHTT affects brain development is vital in the context of planning disease prevention therapies."

HD is a fatal genetic neurodegenerative disease that causes the progressive breakdown of nerve cells in the brain. An estimated 250,000 people in the United States are either diagnosed with, or at risk for, the disease. Symptoms include personality changes, mood swings and depression, forgetfulness and impaired judgment, unsteady gait, and involuntary movements (chorea). Every child of an HD parent has a 50% chance of inheriting the gene. Patients usually survive 10 - 20 years after diagnosis.

Credit: 
IOS Press

Study: Black Americans, women, conservatives more hesitant to trust COVID-19 vaccine

A survey of approximately 5,000 Americans suggests that 31.1 percent of the U.S. public does not intend to get the COVID-19 vaccine once it becomes available to them - and the likelihood of vaccine refusal is highest among Black Americans, women and conservatives.

Timothy Callaghan, assistant professor at the Texas A&M University School of Public Health, led the study with the aim of better understanding the intentions of the American public regarding vaccines. The results were recently published in Social Science and Medicine.

According to the study, survey respondents answered a series of questions about their behaviors and attitudes about COVID-19, including why or why not they intend to pursue vaccination. Women are 71 percent more likely to not to pursue vaccination, researchers found, followed by Blacks at 41 percent.

Survey results also showed that politics play a role: each one-point increase in conservatism increases the odds of vaccine refusal by 18 percent. Those who said they intended to vote for President Donald Trump in the presidential election - the survey was conducted in mid-2020 - were 29 percent more likely to refuse vaccination.

The study revealed two top reasons for vaccine refusal: concerns about safety and effectiveness. However, reasons for vaccine reluctance varied across sub-populations.

For instance, women who were surveyed said they are hesitant based on safety concerns and effectiveness, while surveyed Black Americans said their hesitancy stems from similar concerns plus a lack of financial resources or health insurance.

For conservatives, Callaghan points to previous studies that have shown these people are generally less trusting of vaccines, as well as medical and scientific professionals.

The finding that most surprised Callaghan is that Black individuals, who are being infected with COVID-19 and dying at higher rates, are less likely to vaccinate because of a combination of concerns, including those related to safety and affordability.

"This points to the need for the medical community and policymakers to find ways to both build trust in the vaccine in the African American community and to ensure that it is delivered affordably," Callaghan said.

The authors of the study also state that anti-vaccine advocacy groups "have made a concerted effort" to target Black Americans, writing that if they are successful in framing COVID-19 vaccination in terms of past medical abuses against minority groups, it could decrease the likelihood that racial minorities will pursue COVID-19 vaccination, particularly in light of recent findings emphasizing the implications of peripheral trauma."

Now that COVID-19 vaccine-hesitant populations have been identified, Callaghan plans to explore what kind of health interventions and health promotion efforts are most effective in promoting the vaccine to these populations. Additionally, he said it is important to explore the similarities and differences between populations that are generally vaccine hesitant and populations that are hesitant specifically toward the COVID-19 vaccine.

Credit: 
Texas A&M University

Long-term study finds dozens of new genetic markers associated with lifetime bone growth

Philadelphia, January 6, 2021 - A multidisciplinary team of researchers led by Children's Hospital of Philadelphia (CHOP) has discovered several genetic markers associated with bone mineral accrual, which could ultimately help identify causes of eventual osteoporosis earlier in life through genetic testing. The findings, which were made possible by following a group of children over several years, were published online by the journal Genome Biology.

Osteoporosis is widely considered a disease of old age. However, the accrual of bone density early in life is critical for achieving optimal bone mass in adulthood and influences bone health throughout a person's life. While studies have looked at genetic markers associated with bone health in adulthood, very few have been performed in children during the most critical period of bone growth.

Additionally, genome-wide association studies (GWAS) have attempted to pinpoint genetic markers associated with bone growth, but an improved understanding of the spatial organization of the human genome can reveal underlying causal genes that may have otherwise been missed.

"We wanted to do a GWAS study that measured bone mineral accrual at multiple time points to provide us with proper longitudinal data at ages when the skeleton is growing and developing," said Struan F.A. Grant, PhD, Director of the Center for Spatial and Functional Genomics and the Daniel B. Burke Endowed Chair for Diabetes Research at CHOP and lead author of the study. "By doing a longitudinal study, we had much greater power in a relatively small cohort of patients."

The study team, which included experts in genetics as well as bone biology, compiled data from approximately 11,000 bone density measurements that were conducted as part of the Bone Mineral Density in Childhood Study (BMDCS), a project headed by Babette S. Zemel, PhD, Associate Program Director of the Clinical and Translational Research Center, Director of the Bionutrition Core Laboratory at CHOP and first author of the study. Once the genetic markers were identified, the researchers used a variant-to-gene mapping method to look for both underlying causal variants as well as corresponding effector genes. They further investigated specific genetic markers, or loci, to characterize their impact on osteoblast function.

Using this method, the researchers identified 40 distinct loci - including 35 that had not been previously reported - associated with bone accrual. Several of these loci are associated with fracture risk later in life. Additionally, the researchers identified two novel effector genes that are potentially causative. Finally, they also identified multiple genetic pathways involved in variation in bone accrual that have important roles in determining whether cells eventually become osteoblasts (bone cells) or adipocytes (fat cells).

"This study is one of many that demonstrates how these loci are manifesting themselves earlier in life than we had previously thought," said Zemel. "In this case, our findings may help us better tailor lifestyle interventions, such as exercise and dietary changes, that will help patients later in life, and they may also lead to novel therapeutic interventions."

Credit: 
Children's Hospital of Philadelphia

Detecting CRISPR/Cas gene doping

All athletes want to be at the top of their game when they compete, but some resort to nefarious approaches to achieve peak muscle growth, speed and agility. Recent developments in gene editing technology could tempt athletes to change their DNA to get an edge. Now, researchers reporting in ACS' Analytical Chemistry demonstrate first steps toward detecting this type of doping both in human plasma and in live mice.

The gene editing method called CRISPR/Cas is a popular way for scientists to precisely change the DNA in many organisms, and it recently gained even more attention when key developers of the method were awarded the 2020 Nobel Prize in Chemistry. With this method, researchers add an RNA molecule and a protein into cells. The RNA molecule guides the protein to the appropriate DNA sequence, and then the protein cuts DNA, like a pair of scissors, to allow alterations. Despite the ethical concerns that have been raised about the method's potential application in humans, some athletes could ignore the risks and misuse it to alter their genes. Because CRISPR/Cas changes DNA, it is considered "gene doping" and is banned by the World Anti-Doping Agency, an independent international organization. A sufficient method to detect CRISPR/Cas gene editing needs to be developed, however. So, Mario Thevis and colleagues wanted to see whether they could identify the protein most likely to be used in this type of doping, Cas9 from the bacteria Streptococcus pyogenes (SpCas9), in human plasma samples and in mouse models.

The team spiked the SpCas9 protein into human plasma, then isolated the protein and cut it into pieces. When the pieces were analyzed by mass spectrometry, the researchers found that they could successfully identify unique components of the SpCas9 protein from the complex plasma matrix. In another experiment, inactivated SpCas9, which can regulate gene expression without altering DNA, was spiked into human plasma samples. With a slight modification, the method allowed the team to purify and detect the inactive form. Finally, the team injected mice with SpCas9 and showed that their concentrations peaked in circulating blood after 2 hours and could be detected up to 8 hours after administration into muscle tissue. The researchers say that although much work still needs to be done, this is an initial step toward a test to pinpoint athletes trying to gain an unfair advantage.

Credit: 
American Chemical Society

A better pen-and-ink system for drawing flexible circuits

image: A pen containing conductive ink can draw circuits on a variety of surfaces -- even a loofah (seen here).

Image: 
Adapted from <i>ACS Applied Electronic Materials</i> <b>2020</b>, DOI: 10.1021/acsaelm.0c00866

Conductive ink is a great tool for printing flexible electronic circuits on surfaces. But these inks can be costly, they do not work on some materials, and devices to apply them can plug up. Now, scientists report in ACS Applied Electronic Materials that they have developed inexpensive conductive inks for clog-free ballpoint pens that can allow users to "write" circuits almost anywhere -- even on human skin.

Flexible electronics are widely used in applications such as biosensors, electronic skin and energy storage. Recent advances to produce such devices include pens that can draw circuits on surfaces, without the need for a printer. These pens can write on a variety of textures, and some can even draw on rough or irregular surfaces unsuitable for printing. However, it's difficult to make ballpoint pens that maintain good circuit-writing performance because the tips can clog. Another challenge is that the metal inks typically used in these systems are expensive to make. And it's unclear how stable these pens and inks are over time. So Yu Liao, Jun Qian and colleagues set out to design a cheap and effective pen-and-ink system.

Building on prior work, the scientists developed a water-based ink containing conductive carbon particles composed of graphene nanosheets, multiwalled carbon nanotubes and carbon black. Maleic anhydride modified rosin resin was added as a binder to reduce the ink's solid content and viscosity, and xanthan gum was added to stabilize the dispersion so the carbon wouldn't settle out of the ink. The researchers optimized viscosity and the size of the conductive particles relative to the pen tip to create a system that provided stable and smooth writing performance on both flat and irregular surfaces -- even a loofah. Circuits drawn on paper with the pen withstood multiple cycles of folding without deterioration. The ink remained stable after sitting for 12 hours, released no harmful gases during use and cost much less than others reported in the literature, the researchers note. The pens could be used to draw flexible, wearable electronic devices on soft substrates or human skin.

Credit: 
American Chemical Society